Quote:
Originally Posted by Wpg_Guy
Sutton is scheduled for completion July 2023, little premature to speculate on it’s demise.
|
Goldman Sachs issued guidance yesterday on vaccine distribution.
".. we expect mass immunization to largely complete the reopening process and trigger a reacceleration next spring that will leave full-year growth well above expectations."
Source: National Association of Medicine, Goldman Sachs Global Investment Research
So, GS expects they'll have most of the US population vaccinated with one of the vaccines currently in trial by end of H2 2021.